Azenta received full repayment of a $35 million secured vendor Loan before maturity, including $35,373,333 with accrued interest. The repayment means Azenta now holds the entire $63,000,000 B Medical Systems purchase price in cash, while the related pledge was released and the transaction’s Credit exposure was retired.

Key Highlights

  • Thelema repaid the $35,000,000 principal plus accrued interest, totaling $35,373,333, on September 3, 2026.
  • The vendor loan bore interest at 6.0% per annum and was repaid before its three-month maturity.
  • Azenta received the entire $63,000,000 purchase price in cash, and the share pledge was released.

Azenta, Inc. (NASDAQ: AZTA) received $35 million in full repayment of a secured vendor loan before maturity.

$35 Million Loan Repaid Early

Azenta Germany GmbH provided Thelema S.à r.l. With a secured term loan carrying an aggregate principal amount of $35,000,000. The Facility bore interest at 6.0% per annum, matured three months after funding, and allowed repayment before Maturity without a penalty. The $35,000,000 vendor loan covered part of the $63,000,000 purchase price at closing. On September 3, 2026, Thelema repaid the outstanding loan and accrued interest in an aggregate amount of $35,373,333. The repayment satisfied and discharged all obligations under the Vendor Loan Agreement, which then terminated, while the share pledge was released.

Full Cash Proceeds Complete Divestiture

The company said the repayment completes the divestiture and retires the credit exposure associated with the transaction. The company linked the outcome to its stated approach to Capital allocation.